Precision Through Imaging
Step into the dawn of a revolutionary era, where precision meets innovation through state-of-the-art, image-guided procedures. We innovate to give you a platform to foster your inventions and discoveries. Let our interdisciplinary team expertly navigate the intricacies of protocols, propelling you toward unprecedented success. Welcome to a realm where breakthroughs happen and possibilities are limitless.
Our Flagship Disease model for Testing Drugs and Devices.
Endovascular model of stroke in pigs is our crown jewel. It lets testing biomarkers, diagnostics, therapeutic agents and medical devices in highly clinically relevant scenario. It is performed inside MR scanner; therefore, it allows for an excellent stroke size control. This workflow also seamlessly provides a baseline stroke image critical for long-term studies. Imaging readout is our mainstay, but we are also capable of behavioral testing of neurological deficitis.
Years of experience
With over 20 years of academic experience, we specialize in modeling diseases and testing therapies in animals.
3 models
The backbone of our CRO consists of three meticulously optimized large animal models for central nervous system diseases.
Mission
Our singular mission is to assist customers in efficiently discovering new treatments and devices for improved management of central nervous system diseases.
Testing drugs and devices in large animal models
We handle the challenging aspects of project logistics, including model induction and post-surgical care in large animals, ensuring it is cost-effective for you.
Image-guided neurointerventions
Our distinctive strength lies in precision and reproducibility, achieved through a heavy reliance on imaging. The utilization of image-guided neurointerventions ensures procedures that are minimally invasive, reproducible, precise, and yielding conclusive outcomes.
Partnerships for demanding tasks in projects/grants
We love science as we grew out of academic setting and we are very keen on entering into partnerships for multidimentional, international, interinstitutional demanding projects.
Vision
Modern medicine is putting more pressure on the transition from the old paradigm of population medicine to the new concepts of PRECISION MEDICINE. These new concepts require precise delivery of therapies. The goal of Ti-com is to build a platform for the delivery of therapeutic agents based on biomaterials and image-guided neurointerventions to achieve unprecedented precision and reproducibility.
We are Contract Research Organization
We are specializing in neurointerventions with a focus on large animal models, we prioritize precision and clinical relevance in our approach. Our utilization of state-of-the-art MRI technology enhances the accuracy of our studies, allowing for meticulous assessments and interventions. With a dedicated commitment to advancing neuroscientific research, our organization strives to bridge the gap between preclinical investigations and clinical applications, ultimately contributing to the development of effective interventions and therapies in the field of Central Nervous System disorders.
Latest news
Check out the latest news from our team
08 August 2024
SNOSSA Meeting 2024
The 7th Annual Meeting of the Society for Neuro-Oncology Sub-Saharan Africa (SNOSSA) was held in Harare, the capital of Zimbabwe, from July 25 to 27, 2024.
10 January 2024
SIGN Meeting 2024
Early in 2024, the Society for Image-Guided Neurointerventions (SIGN) held its conference in the stunning and exotic Ramoji Film City, just outside Hyderabad, India.
26 March 2023
Invest Cuffs 2023
Ti-com seeks investment at Invest Cuffs in Cracow. It is the biggest business conference in Poland, at a spectacular ICE Congress Centre.
26 July 2022
SIGN Meeting 2022
Two weeks ago we had the opportunity to be part of an incredibly interesting conference Society for Image-Guided Neurointerventions (SIGN) in the astonishingly charming Warwick Castle.